Literature DB >> 12787214

A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients.

David Herrera1, Mariano Sanz, Soren Jepsen, Ian Needleman, Silvia Roldán.   

Abstract

BACKGROUND: Scaling and root planing (SRP) are the bases of non-surgical therapy in the treatment of periodontitis. However, results from this therapy are often unpredictable and dependable from many different factors.
OBJECTIVES: The aim of this systematic review was to evaluate the effectiveness of the adjunctive use of systemic antimicrobials with scaling and root planing (SRP) vs. SRP alone in the treatment of chronic (CP) or aggressive periodontitis (AgP). SEARCH STRATEGY: Use of computerized databases, namely MEDLINE, the Cochrane Oral Health Group Specialty Trials Register and EMBASE; reference lists from relevant articles were hand-searched; and a hand-search of selected journals until April 2001. SELECTION CRITERIA: Studies were selected if they were designed as controlled clinical trials in which systemically healthy patients with either AgP or CP were treated with SRP plus systemic antimicrobials in comparison with SRP alone or with placebo, for a minimum of 6 months. Main outcome measures were clinical attachment level (CAL) change and probing pocket depth (PPD) change. DATA COLLECTION AND ANALYSIS: Two reviewers extracted independently information regarding quality and study characteristics, in duplicate. Kappa scores determined their agreement. Main results were collected and grouped by drug, disease and PPD category. For the quantitative data synthesis, the data was pooled (when mean differences and standard errors were available), and either a Fixed Effects or Random Effects meta-analysis was used for the analysis.
RESULTS: After an initial selection, 158 papers were identified by the manual and electronic searches; 25 papers were eligible for inclusion. Their quality assessment showed that randomization and allocation concealment methods were seldom reported and blindness was usually not defined clearly. In general, selected studies showed high variability and lack of relevant information for an adequate assessment. Overall, SRP plus systemic antimicrobial groups demonstrated better results in CAL and PPD change than SRP alone or with placebo groups. Only limited meta-analyses could be performed, due to the difficulties in pooling the studies and the lack of appropriate data. This analysis showed a statistically significant additional benefit for spiramycin (PPD change) and amoxicillin/metronidazole (CAL change) in deep pockets.
CONCLUSION: Systemic antimicrobials in conjunction with SRP, can offer an additional benefit over SRP alone in the treatment of periodontitis, in terms of CAL and PPD change, and reduced risk of additional CAL loss. However, differences in study methodology and lack of data precluded an adequate and complete pooling of data for a more comprehensive analyses. It was difficult to establish definitive conclusions, although patients with deep pockets, progressive or 'active' disease, or specific microbiological profile, can benefit more from this adjunctive therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12787214     DOI: 10.1034/j.1600-051x.29.s3.8.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  74 in total

1.  The impact of antimicrobial photodynamic therapy in an artificial biofilm model.

Authors:  Martin Schneider; Gregor Kirfel; Michael Berthold; Matthias Frentzen; Felix Krause; Andreas Braun
Journal:  Lasers Med Sci       Date:  2011-10-02       Impact factor: 3.161

2.  Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: microbiological profile.

Authors:  Arthur B Novaes; Humberto O Schwartz-Filho; Rafael R de Oliveira; Magda Feres; Sandra Sato; Luciene C Figueiredo
Journal:  Lasers Med Sci       Date:  2011-03-12       Impact factor: 3.161

Review 3.  An overview of systematic reviews of the use of systemic antimicrobials for the treatment of periodontitis.

Authors:  C M Faggion; M P Cullinan; M Atieh; J Wasiak
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

4.  Is periodontal disease a public health problem?

Authors:  P Batchelor
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

5.  Health from the hive: propolis as an adjuvant in the treatment of chronic periodontitis - a clinicomicrobiologic study.

Authors:  Nehal N Sanghani; Shivaprasad Bm; Savita S
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 6.  Administration of systemic antibiotics during non-surgical periodontal therapy-a consensus report.

Authors:  B Pretzl; S Sälzer; B Ehmke; U Schlagenhauf; B Dannewitz; H Dommisch; P Eickholz; Y Jockel-Schneider
Journal:  Clin Oral Investig       Date:  2018-10-29       Impact factor: 3.573

7.  Management of Acute Periodontal Abscess Mimicking Acute Apical Abscess in the Anterior Lingual Region: A Case Report.

Authors:  Omar A Alharbi; Muhammad Zubair Ahmad; Atif S Agwan; Durre Sadaf
Journal:  Cureus       Date:  2019-09-08

8.  The adjunctive effect of photodynamic therapy for residual pockets in single-rooted teeth: a randomized controlled clinical trial.

Authors:  Gisele N Campos; Suzana P Pimentel; Fernanda V Ribeiro; Renato C V Casarin; Fabiano R Cirano; Cintia H C Saraceni; Márcio Z Casati
Journal:  Lasers Med Sci       Date:  2012-07-20       Impact factor: 3.161

Review 9.  Lessons learned and unlearned in periodontal microbiology.

Authors:  Ricardo Teles; Flavia Teles; Jorge Frias-Lopez; Bruce Paster; Anne Haffajee
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

10.  Effect of periodontal therapy on the subgingival microbiota over a 2-year monitoring period. I. Overall effect and kinetics of change.

Authors:  Sigmund S Socransky; Anne D Haffajee; Ricardo Teles; Jan L Wennstrom; Jan Lindhe; Anna Bogren; Hatice Hasturk; Thomas van Dyke; Xiaoshan Wang; Jo Max Goodson
Journal:  J Clin Periodontol       Date:  2013-05-27       Impact factor: 8.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.